Skip to main content
Equibles
BCPC logo

BCPC · Balchem Corp · Webcasts, Transcripts & Audio

Track BCPC — free

Use BCPC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BCPC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$166.56 +2.87 (+1.75%) At close · Oct 2
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.33B
Shares
31.88M
Volume · Oct 2 197.32K Avg daily vol (3M) 202.45K

Balchem Corp Webcasts

Earnings calls, investor updates, investor days and conferences for Balchem Corp (BCPC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲23.4% $244.27M $25.25M '22 Q3 22-11-04 ▲9.1% $232.53M $21.41M '22 Q4 23-02-24 ▲1.6% $232.54M $22.71M '23 Q1 23-04-28 ▼2.3% $231.25M $30.11M '23 Q2 23-07-28 ▼5.9% $229.95M $29.07M '23 Q3 23-10-27 ▼1.6% $228.70M $26.65M '23 Q4 24-02-16 ▲3.1% $239.66M $28.99M '24 Q1 24-05-03 ▲1.2% $234.08M $32.07M '24 Q2 24-07-26 ▲4.3% $239.94M $33.84M '24 Q3 24-10-25 ▲4.9% $240.00M $33.58M '24 Q4 25-02-21 ▲4.5% $250.52M $37.05M '25 Q1 25-04-24 ▲9.1% $255.47M $38.28M '25 Q2 25-07-31 ▲11.5% $267.56M $40.29M '25 Q3 25-10-21 ▲9.8% $263.62M $39.23M '25 Q4 26-02-20 ▲8.1% $270.71M $40.28M '26 Q1 26-04-30 LATEST ▲11.2% $284.00M $44.62M '26 Q2 26-07-31
Earnings call
FY26 · Q2
2026-07-31
Balchem Corp (BCPC) Q2 2026 Earnings Call Transcript
Confident tone Animal Nutrition & Health (ANH) performance Choline cognition / Alzheimer's study Credit facility and interest rate
Revenue
$284.00M
▲ 11.2% YoY
Diluted EPS
$1.39
▲ 18.8% YoY
Gross margin
36.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-07-09
Balchem Corp (BCPC) July 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-30
Balchem Corp (BCPC) Q1 2026 Earnings Call Transcript
Confident tone Specialty Products and Plant Nutrition Vidacholine research and marketing Input cost inflation and Middle East conflict
Revenue
$270.71M
▲ 8.1% YoY
Diluted EPS
$1.25
▲ 10.6% YoY
Gross margin
37.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-20
Balchem Corp (BCPC) Q4 2025 Earnings Call Transcript
Confident tone International geographic expansion Animal Nutrition & Health – dairy and monogastric Human Nutrition & Health demand trends
Revenue
$263.62M
▲ 9.8% YoY
Diluted EPS
$1.21
▲ 17.5% YoY
Gross margin
35.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-21
Balchem Corp (BCPC) Q3 2025 Earnings Call Transcript
Confident tone Human Nutrition and Health demand Record financial results and growth streak Specialty Products expansion
Revenue
$267.56M
▲ 11.5% YoY
Diluted EPS
$1.24
▲ 20.4% YoY
Gross margin
35.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
Balchem Corp (BCPC) Q2 2025 Earnings Call Transcript
Confident tone Record financial results and growth across all segments Human Nutrition & Health segment performance Capital allocation and share repurchases
Revenue
$255.47M
▲ 9.1% YoY
Diluted EPS
$1.17
▲ 19.4% YoY
Gross margin
36.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
Balchem Corp (BCPC) Q1 2025 Earnings Call Transcript
Confident tone Record Q1 financial results Tariffs and global trade environment Human Nutrition & Health segment
Revenue
$250.52M
▲ 4.5% YoY
Diluted EPS
$1.13
▲ 27% YoY
Gross margin
35.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-21
Balchem Corp (BCPC) Q4 2024 Earnings Call Transcript
Confident tone Margin Outlook and Mix Animal Nutrition & Health Segment Quarterly and Full-Year Financial Results
Revenue
$240.00M
▲ 4.9% YoY
Diluted EPS
$1.03
▲ 25.6% YoY
Gross margin
36.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-25
Balchem Corp (BCPC) Q3 2024 Earnings Call Transcript
Confident tone Human Nutrition & Health segment strength Animal Nutrition & Health softness Margin expansion and outlook
Revenue
$239.94M
▲ 4.3% YoY
Diluted EPS
$1.03
▲ 14.4% YoY
Gross margin
35.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-26
Balchem Corp (BCPC) Q2 2024 Earnings Call Transcript
Confident tone Human Nutrition & Health segment performance Optifolin+ new product launch Specialty Products and performance gases
Revenue
$234.08M
▲ 1.2% YoY
Diluted EPS
$0.98
▲ 5.4% YoY
Gross margin
35.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-03
Balchem Corp (BCPC) Q1 2024 Earnings Call Transcript
Positive tone VitaCholine Marketing / NY Jets Partnership Human Nutrition & Health (HNH) Segment Performance Animal Nutrition & Health Headwinds
Revenue
$239.66M
▲ 3.1% YoY
Diluted EPS
$0.89
▲ 27.1% YoY
Gross margin
34.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-16
Balchem Corp (BCPC) Q4 2023 Earnings Call Transcript
Confident tone Animal Nutrition & Health Segment Financial Results CureMark / Microencapsulation
Revenue
$228.70M
▼ 1.6% YoY
Diluted EPS
$0.82
▲ 24.2% YoY
Gross margin
32.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-27
Balchem Corp (BCPC) Q3 2023 Earnings Call Transcript
Revenue
$229.95M
▼ 5.9% YoY
Diluted EPS
$0.90
▲ 15.4% YoY
Gross margin
33.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-28
Balchem Corp (BCPC) Q2 2023 Earnings Call Transcript
Revenue
$231.25M
▼ 2.3% YoY
Diluted EPS
$0.93
▲ 1.1% YoY
Gross margin
33.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-28
Balchem Corp (BCPC) Q1 2023 Earnings Call Transcript
Revenue
$232.54M
▲ 1.6% YoY
Diluted EPS
$0.70
▼ 21.3% YoY
Gross margin
31.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-24
Balchem Corp (BCPC) Q4 2022 Earnings Call Transcript
Revenue
$232.53M
▲ 9.1% YoY
Diluted EPS
$0.66
▼ 13.2% YoY
Gross margin
29.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-04
Balchem Corp (BCPC) Q3 2022 Earnings Call Transcript
Revenue
$244.27M
▲ 23.4% YoY
Diluted EPS
$0.78
▲ 1.3% YoY
Gross margin
28.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-29
Balchem Corp (BCPC) Q2 2022 Earnings Call Transcript
Revenue
$236.69M
▲ 17% YoY
Diluted EPS
$0.92
▲ 31.4% YoY
Gross margin
30.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-29
Balchem Corp (BCPC) Q1 2022 Earnings Call Transcript
Revenue
$228.87M
▲ 23.3% YoY
Diluted EPS
$0.89
▲ 23.6% YoY
Gross margin
31.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-18
Balchem Corp (BCPC) Q4 2021 Earnings Call Transcript
Revenue
$213.13M
▲ 17.9% YoY
Diluted EPS
$0.76
▲ 11.8% YoY
Gross margin
30.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-29
Balchem Corp (BCPC) Q3 2021 Earnings Call Transcript
Revenue
$197.87M
▲ 13% YoY
Diluted EPS
$0.77
▲ 16.7% YoY
Gross margin
30.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-30
Balchem Corp (BCPC) Q2 2021 Earnings Call Transcript
Revenue
$202.37M
▲ 16.7% YoY
Diluted EPS
$0.70
▲ 7.7% YoY
Gross margin
29.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-30
Balchem Corp (BCPC) Q1 2021 Earnings Call Transcript
Revenue
$185.66M
▲ 6.4% YoY
Diluted EPS
$0.72
▲ 18% YoY
Gross margin
31.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-19
Balchem Corp (BCPC) Q4 2020 Earnings Call Transcript
Revenue
$180.71M
▲ 8.5% YoY
Diluted EPS
$0.68
▲ 7.9% YoY
Gross margin
31.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-28
Balchem Corp (BCPC) Q3 2020 Earnings Call Transcript
Revenue
$175.14M
▲ 10.4% YoY
Diluted EPS
$0.66
▲ 3.1% YoY
Gross margin
32.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-31
Balchem Corp (BCPC) Q2 2020 Earnings Call Transcript
Revenue
$173.35M
▲ 7.3% YoY
Diluted EPS
$0.65
▲ 6.6% YoY
Gross margin
31.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-01
Balchem Corp (BCPC) Q1 2020 Earnings Call Transcript
Revenue
$174.44M
▲ 11.1% YoY
Diluted EPS
$0.61
▲ 5.2% YoY
Gross margin
31.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-21
Balchem Corp (BCPC) Q4 2019 Earnings Call
Revenue
$166.53M
▲ 1.8% YoY
Diluted EPS
$0.63
▲ 0% YoY
Gross margin
32.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 webcasts
Key facts CIK 9326 CUSIP 057665200 13F (30d) 14 filings 11 filers Visit website